医疗服务板块11月20日跌0.93%，贝瑞基因领跌，主力资金净流出11.45亿元

Market Overview - The medical services sector declined by 0.93% on November 20, with Bei Rui Gene leading the drop [1] - The Shanghai Composite Index closed at 3931.05, down 0.4%, while the Shenzhen Component Index closed at 12980.82, down 0.76% [1] Stock Performance - Notable gainers included: - Bid Medicine (688073) with a closing price of 76.14, up 5.34% [1] - Sunshine Nuohe (688621) at 58.59, up 2.59% [1] - Pukos (301257) at 44.85, up 1.36% [1] - Major decliners included: - Bei Rui Gene (000710) at 12.69, down 9.10% [2] - Chengda Pharmaceutical (301201) at 53.04, down 7.76% [2] - Weimenfei (301509) at 34.39, down 5.78% [2] Capital Flow - The medical services sector experienced a net outflow of 1.145 billion yuan from institutional investors, while retail investors saw a net inflow of 990 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors increased their positions [2] Individual Stock Capital Flow - Notable capital flows for specific stocks included: - Wu Medicine (603259) with a net inflow of 63.84 million yuan from institutional investors [3] - Sunshine Nuohe (688621) saw a net inflow of 7.25 million yuan from institutional investors [3] - Bid Medicine (688073) had a net inflow of 2.46 million yuan from institutional investors [3]